International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5681/zenodo.13825310
Original Research Article
Role of Vitamin D Deficiency in Insulin Resistance among Type 2 Diabetics
Published
Nov. 5, 2024
Abstract

Background: Vitamin D deficiency has emerged as a potential contributor to insulin resistance in type 2 diabetes mellitus (T2DM). This study investigated the relationship between vitamin D status and insulin resistance among patients with T2DM.Methods: A prospective cross-sectional study was conducted at a tertiary care center involving 328 T2DM patients. Serum 25-hydroxyvitamin D levels, glycemic parameters, and insulin resistance (HOMA-IR) were measured. Multiple linear regression analysis was performed to identify independent predictors of insulin resistance. Results: The prevalence of vitamin D deficiency (<20 ng/mL) was 54.6%, with a mean serum level of 20.8 ± 8.4 ng/mL in the study population. A strong inverse correlation was observed between vitamin D levels and HOMA-IR (r=-0.642, p<0.001). Vitamin D deficient patients demonstrated significantly higher HOMA-IR values (6.48 ± 2.82) compared to those with sufficient levels (3.69 ± 1.46, p<0.001). Multiple regression analysis identified vitamin D levels (β=-0.284, p<0.001) as an independent predictor of insulin resistance, along with BMI (β=0.308, p<0.001) and physical activity (β=-0.242, p=0.002). HbA1c levels were significantly higher in vitamin D deficient patients (8.2 ± 1.4%) compared to those with sufficient levels (7.1 ± 0.9%, p=0.002).Conclusion: A significant inverse association exists between vitamin D levels and insulin resistance in T2DM patients. The high prevalence of vitamin D deficiency and its independent association with insulin resistance suggests the potential therapeutic importance of maintaining adequate vitamin D status in T2DM management.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
992 Views
59 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved